Ischemia-Modified Albumin as a New Biomarker in Predicting Oxidative Stress in Alopecia Areata

    Hatice Ataş, Müzeyyen Gönül, Yasin Öztürk, Mustafa Kavutçu
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that ischemia-modified albumin (IMA) may be a promising biomarker of oxidative stress in patients with alopecia areata, offering better potential compared to other oxidative stress markers.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results